9OBN image
Deposition Date 2025-04-22
Release Date 2026-01-21
Last Version Date 2026-05-27
Entry Detail
PDB ID:
9OBN
Keywords:
Title:
Crystal structure of malaria transmission-blocking antigen Pfs48/45 C-terminal domain in complex with nanobody B2
Biological Source:
Source Organism(s):
Expression System(s):
Method Details:
Experimental Method:
Resolution:
2.50 Å
R-Value Free:
0.25
R-Value Work:
0.20
R-Value Observed:
0.21
Space Group:
P 2 21 21
Macromolecular Entities
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:Gametocyte surface protein P4
Gene (Uniprot):PF45/48
Mutagens:H308Y, G397L, I402V
Chain IDs:A, B, C, D
Chain Length:150
Number of Molecules:4
Biological Source:Plasmodium falciparum 3D7
Protein Blast
Polymer Type:polypeptide(L)
Molecule:Nanobody B2
Chain IDs:E, F (auth: H), G, H (auth: F)
Chain Length:131
Number of Molecules:4
Biological Source:Vicugna pacos
Primary Citation
Pfs48/45 nanobodies block Plasmodium falciparum transmission.
Plos Pathog. 22 e1013884 e1013884 (2026)
PMID: 41592139 DOI: 10.1371/journal.ppat.1013884

Abstact

Malaria parasite fertilisation occurs within the Anopheles mosquito midgut. Interventions that inhibit parasite fertilisation prevent ongoing transmission and are important for malaria elimination efforts. Pfs48/45 and Pfs230 are two leading transmission-blocking vaccine candidates. Both proteins form a complex on the surface of sexual stage parasites and are essential for male fertility. Here we have identified nanobodies against Pfs48/45 that recognise gametocytes and have strong transmission-reducing activity. The crystal structure of our most potent nanobody in complex with Pfs48/45 reveals it binds a distinct epitope to TB31F, a leading transmission-blocking monoclonal antibody but to similar epitopes as RUPA-44 and RUPA-117. These results demonstrate the potential of nanobodies as a versatile antibody format that can reduce malaria transmission.

Legend

Protein

Chemical

Disease

Primary Citation of related structures
Feedback Form
Name
Email
Institute
Feedback